Suppr超能文献

慢性阻塞性肺疾病中树突状细胞、自然杀伤细胞和调节性 T 细胞之间失调串扰的模型。

A model of dysregulated crosstalk between dendritic, natural killer, and regulatory T cells in chronic obstructive pulmonary disease.

机构信息

Graduate Program in Immunology, University of Michigan, Ann Arbor, MI, USA.

Graduate Program in Immunology, University of Michigan, Ann Arbor, MI, USA; Pulmonary & Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA; Pulmonary and Critical Care Medicine Section, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.

出版信息

Trends Immunol. 2024 Jun;45(6):428-441. doi: 10.1016/j.it.2024.04.010. Epub 2024 May 18.

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by infiltration of the airways and lung parenchyma by inflammatory cells. Lung pathology results from the cumulative effect of complex and aberrant interactions between multiple cell types. However, three cell types, natural killer cells (NK), dendritic cells (DCs), and regulatory T cells (Tregs), are understudied and underappreciated. We propose that their mutual interactions significantly contribute to the development of COPD. Here, we highlight recent advances in NK, DC, and Treg biology with relevance to COPD, discuss their pairwise bidirectional interactions, and identify knowledge gaps that must be bridged to develop novel therapies. Understanding their interactions will be crucial for therapeutic use of autologous Treg, an approach proving effective in other diseases with immune components.

摘要

慢性阻塞性肺疾病(COPD)的特征是气道和肺实质被炎症细胞浸润。肺病理学是由多种细胞类型之间复杂和异常的相互作用的累积效应所致。然而,自然杀伤细胞(NK)、树突状细胞(DC)和调节性 T 细胞(Treg)这三种细胞类型的研究还很不足,也未得到充分重视。我们提出,它们之间的相互作用对 COPD 的发展有重要贡献。在这里,我们强调了与 COPD 相关的 NK、DC 和 Treg 生物学的最新进展,讨论了它们之间的双向相互作用,并确定了必须弥合的知识差距,以开发新的治疗方法。了解它们的相互作用对于使用自体 Treg 的治疗方法至关重要,这种方法在具有免疫成分的其他疾病中已被证明是有效的。

相似文献

1
3
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.
Cochrane Database Syst Rev. 2014 Mar 26;2014(3):CD010844. doi: 10.1002/14651858.CD010844.pub2.
5
[Regulatory T cells in chronic obstructive pulmonary disease].
Arch Cardiol Mex. 2013 Jan-Mar;83(1):45-54. doi: 10.1016/j.acmx.2013.01.010.
6
Self-management interventions for people with chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
7
Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2016 Dec 19;12(12):CD005074. doi: 10.1002/14651858.CD005074.pub4.
8
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
9
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
10
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

引用本文的文献

1
Machine learning developed an immune evasion signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma.
Front Cell Dev Biol. 2025 Jun 19;13:1622345. doi: 10.3389/fcell.2025.1622345. eCollection 2025.
2
Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases.
Front Immunol. 2025 Jan 23;16:1536020. doi: 10.3389/fimmu.2025.1536020. eCollection 2025.

本文引用的文献

2
Tipping the balance toward transplantation tolerance: in vivo therapy using a mutated IL-2.
J Clin Invest. 2024 Mar 1;134(5):e178570. doi: 10.1172/JCI178570.
3
A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models.
J Clin Invest. 2024 Mar 1;134(5):e173107. doi: 10.1172/JCI173107.
4
Natural killer cell therapies.
Nature. 2024 Feb;626(8000):727-736. doi: 10.1038/s41586-023-06945-1. Epub 2024 Feb 21.
5
Smoking changes adaptive immunity with persistent effects.
Nature. 2024 Feb;626(8000):827-835. doi: 10.1038/s41586-023-06968-8. Epub 2024 Feb 14.
8
Regulatory T cells in lung disease and transplantation.
Biosci Rep. 2023 Oct 31;43(10). doi: 10.1042/BSR20231331.
9
Does Chronic Obstructive Pulmonary Disease Originate from Different Cell Types?
Am J Respir Cell Mol Biol. 2023 Nov;69(5):500-507. doi: 10.1165/rcmb.2023-0175PS.
10
A Single-Cell Atlas of Small Airway Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.
Am J Respir Crit Care Med. 2023 Aug 15;208(4):472-486. doi: 10.1164/rccm.202303-0534OC.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验